According to SPER Market Research, Because conventional diagnostics are so expensive, the market for digital telepathology is growing. Telepathology acceptance is becoming more clinically necessary to improve current patient diagnostic imaging events. Thanks to new imaging technology, pathologists and pathologists-in-training now have access to a variety of resources that will help them collaborate, continue to provide patient care remotely, and improve online learning. This paradigm change will affect both how we operate on a day-to-day basis during the pandemic and how we teach pathology online in the future. It might potentially result in modifications to the regulations governing the acceptance and use of digital pathology systems for diagnostic purposes.
Digital Telepathology Market Overview:
- Forecast CAGR (2022–2032): 9.6%
- Forecast Market Size (2032): 2.19 billion
Digital pathology was developed years ago to allow pathologists to collaborate on cases remotely and improve the accuracy of diagnostic procedures by transferring digital images among laboratories. Prior to the COVID-19 pandemic, the US lagged behind most industrialized nations in the use of digital pathology because of the rigid regulatory regulations imposed by the US Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS). The FDA relaxed some of its requirements for authorizing and certifying technology linked to digital pathology in order to meet the demands of the pandemic response. In a similar spirit, the CMS removed onerous CLIA requirements, allowing pathologists to use digital pathology tools while working remotely. The COVID-19 pandemic facilitated the widespread use of digital pathology for remote diagnosis as a result.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/digital-telepathology-market.aspx?sample=1
Digital Telepathology Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; GE Healthcare, Glencoe Software, Inspirata, Kanteron Systems, Leica Biosystems, MikroSkan Technologies Inc., Olympus Corporation, OptraSCAN, Philips Healthcare, Ventana Medical Systems Inc.
Global Digital Telepathology Market Segmentation:
By Type: Based on the Type, Global Digital Telepathology Market is segmented as; Education, Medical, Other.
By Application: Based on the Application, Global Digital Telepathology Market is segmented as; Diagnosis, Education, Research, Others.
By End User: Based on the End User, Global Digital Telepathology Market is segmented as; Academic Institutes, Diagnostic Centers and Pathology Clinics, Hospital, Pharmaceutical and Biotech Companies, Research Organizations, Others.
By Region: The largest market is in North America, where moderate growth is anticipated over the following ten years. This is brought on by a robust healthcare system, laws like the Affordable Care Act, a high incidence of different cancers, and an aging population that need medical attention. Additionally, it is assisted by top-notch medical research and education facilities, quick technological uptake, and the availability of government compensation in these crucial fields in North America. Due to industrialisation and investment prospects in healthcare facilities, Canada has a significant development potential.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.
For More Information, refer to below link: –
Digital Telepathology Market Growth
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant — USA
SPER Market Research
+1–347–460–2899
